openPR Logo
Press release

ALLELE Returns with Explosive New Single "Red Heart Love" - A Triumphant Comeback from the Band Behind the Smash Hit "Stitches"

07-17-2025 09:02 AM CET | Leisure, Entertainment, Miscellaneous

Press release from: ABNewswire

Allele 2025

Allele 2025

Rock fans, rejoice - ALLELE is officially back with new song "Red Heart Love"
Jacksonville, FL - Rock fans rejoice... ALLELE is officially back. The hard hitting band who made waves with their unforgettable song 'Stitches', best known from it's feature on WWE Smackdown vs Raw, has returned with a new single that reclaims their spot in the modern rock landscape. Titled 'Red Heart love' the track is a soaring, emotionally raw anthem that captures everything Allele is known for: Heavy riffs, melodic hooks and unrelenting passion.

The bands new lineup is a powerhouse of talent featuring:

Wally Wood - Vocals

Joey Rodriguez - Guitar

Billy Grey (Fozzy) - Guitar

Tyler Hensley - Bass

Dusty Winterrowd - Drums

This new era of Allele blends years of experience with renewed energy and purpose. 'Red Heart Love' show the bands evolution lyrically. Diving deep into the vulnerability of giving someone everything, heart and soul with scars included. It's melodic and moody but still aggressive and unflinching, a perfect balance that longtime fans will recognize and new fans will instantly connect with.

"We wanted to come back with something that felt honest," says frontman Wally Wood. This track delves deep into the emotional landscape of love, hope, and healing portraying the journey of bleeding for what or who one believes in, even when it seems lost. 'Red Heart Love' will resonate with those who have faced heartbreak, representing the struggle to piece one's self back together after feeling shattered into a million pieces.

The song serves as a reminder that it's possible to find what once felt lost and to hold onto it fiercely. 'Red Heart Love' embraces all who seek to reclaim their sense of wholeness and connection. It's an anthem about bleeding for what or who you believed in but thought was lost. To find it again and never let go of it. This is how we feel and why we believe in this band. Now more than ever.

" 'Red Heart Love' is for everyone, all of us who have been broken and want to be made whole again. With more new music in the works and rumors of touring beginning to circulate, Allele is proving they're not just back, they're here to make an impact. 'Red Heart Love' is available on all streaming platforms and you can check out the band on all their socials to keep up with everything ALLELE.

Media Contact
Company Name: Allele Band
Contact Person: Wally Wood
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=allele-returns-with-explosive-new-single-red-heart-love-a-triumphant-comeback-from-the-band-behind-the-smash-hit-stitches]
Country: United States
Website: https://www.alleleofficial.com/about

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ALLELE Returns with Explosive New Single "Red Heart Love" - A Triumphant Comeback from the Band Behind the Smash Hit "Stitches" here

News-ID: 4107614 • Views:

More Releases from ABNewswire

Europe Garage Door Market Volume to Surge to 2.36 Million Units by 2030 as EU Housing Plan Adds 1.2 Million Homes Across 15 Major Urban Areas - Arizton
Europe Garage Door Market Volume to Surge to 2.36 Million Units by 2030 as EU Ho …
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025-2030. According to Arizton latest research report, Europe garage door market [https://www.arizton.com/market-reports/europe-garage-doors-market]is growing at a CAGR of 3.10% during 2024-2030. Looking for More Information? Click: https://www.arizton.com/market-reports/europe-garage-doors-market Report Scope: MARKET SIZE - REVENUE (2030): USD 3.20 Billion MARKET SIZE - REVENUE (2024): USD 2.66 Billion CAGR - REVENUE (2024-2030): 3.10% MARKET SIZE - VOLUME (2030): 2.36 Million Units HISTORIC YEAR: 2021-2023 BASE YEAR: 2024 FORECAST YEAR: 2025-2030 MARKET
Influenza Pipeline Outlook 2025 - Clinical Trials, Treatment, ROA, Medication, MOA, Revenue Share, Companies by DelveInsight
Influenza Pipeline Outlook 2025 - Clinical Trials, Treatment, ROA, Medication, M …
The Influenza pipeline is experiencing unprecedented growth, driven by 120+ active players, breakthrough therapies, and recent FDA fast-track designations, signaling a transformative decade ahead in Influenza treatment. Influenza Pipeline Summary DelveInsight's Influenza Emerging Drugs report highlights innovative therapies advancing the treatment and prevention of influenza. Key candidates include Moderna's mRNA-1010, a Phase III vaccine encoding HA glycoproteins of WHO-recommended strains; SAB Biotherapeutics' SAB-176, a quadrivalent, broadly neutralizing polyclonal antibody for severe influenza;
Chronic Refractory Cough Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, IND, and Companies
Chronic Refractory Cough Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDM …
DelveInsight's, "Chronic Refractory Cough Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Chronic Refractory Cough pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
PCSK9 Inhibitors Market Landscape: Clinical Pipeline, Competitive Strategies, and Growth Drivers Analysis by Delveinsight | AstraZeneca, Amgen, Regeneron, Sanofi, NOVARTIS, Merck, LIB Therapeutics
PCSK9 Inhibitors Market Landscape: Clinical Pipeline, Competitive Strategies, an …
DelveInsight's PCSK9 Inhibitors Market Report highlights strong growth potential, with the 7MM market projected to expand significantly by 2034 from USD 2B in 2023. The U.S. leads with ~USD 900M. Key players include Sanofi, Regeneron, Amgen, AstraZeneca, LIB Therapeutics, Merck, Novartis, Alnylam, Aqur Biosciences, and CiVi Biopharma. Current leaders PRALUENT and REPATHA dominate, while pipeline assets like LIB003 and MK-0616 signal the next wave of innovation. DelveInsight's comprehensive [https://www.delveinsight.com/report-store/pcsk9-inhibitors-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report, provides

All 5 Releases


More Releases for Allele

Allele to Release Point of Origin Remastered to All Digital Retailers
Allele Taps Rock Sun Records/Virgin Music Group to Release Their Landmark Album Point of Origin Remastered Florida hard rock/alt-metal band Allele is proud to announce the upcoming release of Point of Origin Remastered, set to hit all major digital retailers via Rock Sun Records/Virgin Music Group. The band's classic debut album, originally released in 2005, has been given a whole new lease on life thanks to the skilled hand of Genius
Cell Reprogramming Market May See a Big Move| Allele Biotech, Alstem, Stemcell T …
Archive Market Research published a new research publication on "Cell Reprogramming Market" with 230+ pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cell Reprogramming market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in the study
Cell Reprogramming Market Set to Witness Significant Growth by 2023-2030: Allele …
This research report provides an overview and forecast of the Cell Reprogramming Market for the years 2023 to 2030, including product specifications, technological developments, and key manufacturers. The research explores market obstacles like market demand, market share for the industry, CAGR, current market trends, and competitive vendor strategies. The research identifies and manages the several Cell Reprogramming market growth factors needed for a successful operation. This report is
Gene Editing Technology Market to See Booming Growth | CRISPR Therapeutics, Sigm …
The latest study released on the Global Gene Editing Technology Market by AMA Research evaluates market size, trend, and forecast to 2027. The Gene Editing Technology market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key
Gene Editing Technology Market May See a Big Move : Major Giants Cellectics, Edi …
Latest released the research study on Global Gene Editing Technology Market, offers a detailed overview of the factors influencing the global business scope. Gene Editing Technology Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Gene Editing Technology Market. The study covers emerging
Gene Editing Market 2025 | AstraZeneca, Cellectis, Editas Medicine, Dharmacon, Q …
Global Gene Editing Market: Snapshot Gene editing or genome editing is the targeted insertion or modification of cells in living organism or cells and the method has come to occupy a crucial part of biomedical researches, constantly transforming various disciplines of life sciences. Over the past few years, continuous advancements in gene-editing technologies have led to the advent of several versatile methods, which have enabled investigators to introduce a number